Impact of COVID-19 on the thyroid gland: an update.
Impact of COVID-19 on the thyroid gland: an update.
复制标题
DOI:
10.1007/s11154-020-09615-z
复制
发表时间:
2021-12
影响因子:
8.2
通讯作者:
Trimboli P
中科院分区:
文献类型:
--
作者:
Scappaticcio L;Pitoia F;Esposito K;Piccardo A;Trimboli P
Coronavirus disease 2019 (COVID-19) is the pandemic of the new millennium. COVID-19 can cause both pulmonary and systemic inflammation, potentially determining multi-organ dysfunction. Data on the relationship between COVID-19 and thyroid have been emerging, and rapidly increasing since March 2020. The thyroid gland and the virus infection with its associated inflammatory-immune responses are known to be engaged in complex interplay. SARS-CoV-2 uses ACE2 combined with the transmembrane protease serine 2 (TMPRSS2) as the key molecular complex to infect the host cells. Interestingly, ACE2 and TMPRSS2 expression levels are high in the thyroid gland and more than in the lungs. Our literature search provided greater evidence that the thyroid gland and the entire hypothalamic–pituitary–thyroid (HPT) axis could be relevant targets of damage by SARS-CoV-2. Specifically, COVID-19-related thyroid disorders include thyrotoxicosis, hypothyroidism, as well as nonthyroidal illness syndrome. Moreover, we noticed that treatment plans for thyroid cancer are considerably changing in the direction of more teleconsultations and less diagnostic and therapeutical procedures. The current review includes findings that could be changed soon by new results on the topic, considering the rapidity of worldwide research on COVID-19.
登录
查看更多内容
DOI:
10.15557/pimr.2020.0003
发表时间:
2020-01-01
影响因子:
3.6
作者:
通讯作者:
--
影响因子:
5.8
作者:
Brancatella, Alessandro;Ricci, Debora;Latrofa, Francesco
通讯作者:
Latrofa, Francesco
影响因子:
28.2
作者:
Dai, Mengyuan;Liu, Dianbo;Cai, Hongbing
通讯作者:
Cai, Hongbing
影响因子:
158.5
作者:
Ackermann, Maximilian;Verleden, Stijn E.;Jonigk, Danny
通讯作者:
Jonigk, Danny
影响因子:
6.6
作者:
Chen, Min;Zhou, Weibin;Xu, Weiwei
通讯作者:
Xu, Weiwei